How Bain’s $3.3B deal for a centuries-old Japanese pharma came to fruition

About two and a half years before they sealed a $3.3 billion deal, Bain Capital and its life sciences team started courting the leadership of Tanabe Pharma and its parent Mitsubishi Chemical ...